Cargando…
Orodispersible Film (ODF) Platform Based on Maltodextrin for Therapeutical Applications
Orodispersible film (ODF) is a new dosage form that disperses rapidly in the mouth without water or swallowing. The main ingredient of an ODF is a polymer that can be both of natural or synthetic origin. Maltodextrin is a natural polymer, mainly used in pharmaceutical and nutraceutical fields. This...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9607423/ https://www.ncbi.nlm.nih.gov/pubmed/36297447 http://dx.doi.org/10.3390/pharmaceutics14102011 |
_version_ | 1784818540212125696 |
---|---|
author | Cupone, Irma E. Sansone, Andrea Marra, Fabio Giori, Andrea M. Jannini, Emmanuele A. |
author_facet | Cupone, Irma E. Sansone, Andrea Marra, Fabio Giori, Andrea M. Jannini, Emmanuele A. |
author_sort | Cupone, Irma E. |
collection | PubMed |
description | Orodispersible film (ODF) is a new dosage form that disperses rapidly in the mouth without water or swallowing. The main ingredient of an ODF is a polymer that can be both of natural or synthetic origin. Maltodextrin is a natural polymer, mainly used in pharmaceutical and nutraceutical fields. This review aims to examine the literature regarding ODFs based on maltodextrin as the platform for developing new products for therapeutical application. ODFs based on maltodextrin contain plasticizers that enhance their flexibility and reduce their brittleness. Surfactants; fillers, such as homopolymer and copolymer of vinylacetate; flavour and sweetener were introduced to improve ODF characteristics. Both water-soluble and insoluble APIs were introduced up to 100 mg per dosage unit. The solvent casting method and hot-melt extrusion are the most useful techniques for preparing ODFs. In particular, the solvent casting method allows manufacturing processes to be developed from a lab scale to an industrial scale. ODFs based on maltodextrin are characterized in terms of mechanical properties, dissolution rate, taste and stability. ODFs made of maltodextrin, developed by IBSA, were tested in vivo to evaluate their bioequivalence and efficacy and were demonstrated to be a valid alternative to the marketed oral dosage forms. |
format | Online Article Text |
id | pubmed-9607423 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-96074232022-10-28 Orodispersible Film (ODF) Platform Based on Maltodextrin for Therapeutical Applications Cupone, Irma E. Sansone, Andrea Marra, Fabio Giori, Andrea M. Jannini, Emmanuele A. Pharmaceutics Review Orodispersible film (ODF) is a new dosage form that disperses rapidly in the mouth without water or swallowing. The main ingredient of an ODF is a polymer that can be both of natural or synthetic origin. Maltodextrin is a natural polymer, mainly used in pharmaceutical and nutraceutical fields. This review aims to examine the literature regarding ODFs based on maltodextrin as the platform for developing new products for therapeutical application. ODFs based on maltodextrin contain plasticizers that enhance their flexibility and reduce their brittleness. Surfactants; fillers, such as homopolymer and copolymer of vinylacetate; flavour and sweetener were introduced to improve ODF characteristics. Both water-soluble and insoluble APIs were introduced up to 100 mg per dosage unit. The solvent casting method and hot-melt extrusion are the most useful techniques for preparing ODFs. In particular, the solvent casting method allows manufacturing processes to be developed from a lab scale to an industrial scale. ODFs based on maltodextrin are characterized in terms of mechanical properties, dissolution rate, taste and stability. ODFs made of maltodextrin, developed by IBSA, were tested in vivo to evaluate their bioequivalence and efficacy and were demonstrated to be a valid alternative to the marketed oral dosage forms. MDPI 2022-09-22 /pmc/articles/PMC9607423/ /pubmed/36297447 http://dx.doi.org/10.3390/pharmaceutics14102011 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Cupone, Irma E. Sansone, Andrea Marra, Fabio Giori, Andrea M. Jannini, Emmanuele A. Orodispersible Film (ODF) Platform Based on Maltodextrin for Therapeutical Applications |
title | Orodispersible Film (ODF) Platform Based on Maltodextrin for Therapeutical Applications |
title_full | Orodispersible Film (ODF) Platform Based on Maltodextrin for Therapeutical Applications |
title_fullStr | Orodispersible Film (ODF) Platform Based on Maltodextrin for Therapeutical Applications |
title_full_unstemmed | Orodispersible Film (ODF) Platform Based on Maltodextrin for Therapeutical Applications |
title_short | Orodispersible Film (ODF) Platform Based on Maltodextrin for Therapeutical Applications |
title_sort | orodispersible film (odf) platform based on maltodextrin for therapeutical applications |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9607423/ https://www.ncbi.nlm.nih.gov/pubmed/36297447 http://dx.doi.org/10.3390/pharmaceutics14102011 |
work_keys_str_mv | AT cuponeirmae orodispersiblefilmodfplatformbasedonmaltodextrinfortherapeuticalapplications AT sansoneandrea orodispersiblefilmodfplatformbasedonmaltodextrinfortherapeuticalapplications AT marrafabio orodispersiblefilmodfplatformbasedonmaltodextrinfortherapeuticalapplications AT gioriandream orodispersiblefilmodfplatformbasedonmaltodextrinfortherapeuticalapplications AT janniniemmanuelea orodispersiblefilmodfplatformbasedonmaltodextrinfortherapeuticalapplications |